Avantax Planning Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $367K | Sell |
|
|||||
|
2025
Q2 | $408K | Sell |
|
|||||
|
2025
Q1 | $415K | Buy |
|
|||||
|
2024
Q4 | $338K | Buy |
|
|||||
|
2024
Q3 | $280K | Sell |
|
|||||
|
2024
Q2 | $252K | Sell |
|
|||||
|
2024
Q1 | $273K | Sell |
|
|||||
|
2023
Q4 | $355K | Sell |
|
|||||
|
2023
Q3 | $337K | Buy |
|
|||||
|
2023
Q2 | $297K | Buy |
|
|||||
|
2023
Q1 | $319K | Sell |
|
|||||
|
2022
Q4 | $342K | Buy |
|
|||||
|
2022
Q3 | $229K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $202K | Buy |
|
|||||
|
2021
Q4 | $205K | Sell |
|
|||||
|
2021
Q3 | $231K | Hold |
|
|||||
|
2021
Q2 | $227K | Sell |
|
|||||
|
2021
Q1 | $253K | Sell |
|
|||||
|
2020
Q4 | $277K | Sell |
|
|||||
|
2020
Q3 | $370K | Buy |
|
|||||
|
2020
Q2 | $380K | Buy |
|
|||||
|
2020
Q1 | $331K | Sell |
|
|||||
|
2019
Q4 | $611K | Sell |
|
|||||
|
2019
Q3 | $640K | Buy |
|
|||||
|
2019
Q2 | $659K | Buy |
|
|||||
|
2019
Q1 | $603K | Buy |
|
|||||
|
2018
Q4 | $456K | Buy |
|
|||||
|
2018
Q3 | $560K | Sell |
|
|||||
|
2018
Q2 | $620K | Sell |
|
|||||
|
2018
Q1 | $665K | Sell |
|
|||||
|
2017
Q4 | $644K | Sell |
|
|||||
|
2017
Q3 | $888K | Sell |
|
|||||
|
2017
Q2 | $1.49M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Sell |
|
|||||
|
2016
Q4 | $1.41M | Buy |
|